# Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

> **NCT05548504** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Odense University Hospital** · enrollment: 182 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Stage III
- Radiotherapy Side Effect
- Frailty

## Interventions

- **RADIATION:** Photon
- **RADIATION:** Proton

## Key facts

- **NCT ID:** NCT05548504
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05548504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05548504, "Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05548504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*